of recurrent serious ischemic events despite standard medical therapy, has been clinically challenging. A

resistance and promising directions for targeted therapy. This review presents the results of scientific

in the expression of miRNAs) and designing their targeted therapy using specific miRNAs as targets. This article

. Angiotensin-Receptor-Neprilysin-Inhibitors (ARNIs) are an established HFrEF therapy which increases

Сунитиниб в терапии метастатического почечно-клеточного ракаcytokine therapy

Особенности влияния различных аппликационных адгезивных средств в комплексе местного лечения рецидивирующих афт полости рта у пациентов на фоне клинических проявлений классических и опосредованных гиперсекреторных заболеваний желудочно-кишечного трактаPeculiarities of the effect of various application adhesives in the complex of topical treatment

Возможности профилактики тошноты при цитостатической терапии: обзор литературы и клиническое наблюдениеPossibilities of prevention of nausea during cytostatic therapy: literature review and clinical

investigations and clinical trials employed enhanced MSCs-dependent therapies in treatment of inflammatory